Ocular Therapeutix
OCUL
OCUL
75 hedge funds and large institutions have $70.2M invested in Ocular Therapeutix in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
11
Increased
29
Reduced
12
Closed
4
Calls
$506K
Puts
$441K
Net Calls
+$65K
Net Calls Change
-$519K
Top Buyers
| 1 |
DAM
1
Deltec Asset Management
New York
|
$6.11M |
| 2 |
MWP
2
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
|
$813K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$6.11M |
| 4 |
4
BlackRock
New York
|
$9.34M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$2.05M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
76
Sio Capital Management
New York
| – | -$263K | -59,668 | Closed |
|
77
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$201K | -45,600 | Closed |
|
|
NA
78
NewEdge Advisors
New Orleans,
Louisiana
| – | -$124K | -28,250 | Closed |
|
|
FANJ
79
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$2K | -400 | Closed |
|